Cancer Gene Therapy

Clinical Trial Begins for Malignant Gliomas

Published in Gene Therapy Weekly, September 25th, 1995

A novel gene therapy for patients with malignant gliomas, invariably fatal brain tumors, is being tested in clinical trials at Columbia-Presbyterian Medical Center, New York, New York, and several other sites in the U.S. and Israel.

Each year, approximately 17,000 people in the United States are diagnosed with primary brain tumors (those that originate in the brain). Malignant gliomas, fast-growing and invasive tumors, account for about one third of these cases. Aggressive treatment - surgical removal of the tumor, followed by radiation - often helps to lessen symptoms and improve quality of life, but the prognosis for such patients remains grim. Malignant gliomas...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (1995-09-25)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry